At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
MSB Mesabi
Trading 07-15 11:12:13 EDT
25.41
-0.05
-0.20%
High25.68Low25.10Vol3.77K
Open25.68D1 Closing25.46Amplitude2.28%
Mkt Cap333.38MTradable Cap333.12MTotal Shares13.12M
T/O95.65KT/O Rate0.03%Tradable Shares13.11M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Mesabi Trust Declares $0.05 Per Unit Distribution Payable Aug. 20
Reuters  ·  04:45
Mesabi Trust Declares $0.05 Per Unit Distribution Payable Aug. 20
Press Release: Mesabi Trust Press Release
Dow Jones  ·  04:05
Press Release: Mesabi Trust Press Release
The Metals Royalty Company Announces Completion of First Production Blast at Mesabi Metallics
TIPRANKS  ·  07-14 00:30
The Metals Royalty Company Announces Completion of First Production Blast at Mesabi Metallics
Inter Launches Wearables in the U.S., Taking Banking Beyond the Phone
GlobeNewswire  ·  07-13 21:16
Inter Launches Wearables in the U.S., Taking Banking Beyond the Phone
Metals Company completes first production blast at Mesabi Metallics
TIPRANKS  ·  07-13 19:35
Metals Company completes first production blast at Mesabi Metallics
Mesoblast (ASX:MSB) Is Up 8.7% After Strong Ryoncil Debut And FDA BLA Milestone - Has The Bull Case Changed?
Simply Wall St.  ·  07-12
Mesoblast (ASX:MSB) Is Up 8.7% After Strong Ryoncil Debut And FDA BLA Milestone - Has The Bull Case Changed?
Press Release: Ryoncil(r) Delivers Net Revenue of Us$36m for the Fourth Quarter Ended 30 June 2026
Dow Jones  ·  07-10
Press Release: Ryoncil(r) Delivers Net Revenue of Us$36m for the Fourth Quarter Ended 30 June 2026
Why Mesoblast (ASX:MSB) Is Up 9.3% After FDA Accepts Modular BLA Review For Rexlemestrocel-L
Simply Wall St.  ·  07-04
Why Mesoblast (ASX:MSB) Is Up 9.3% After FDA Accepts Modular BLA Review For Rexlemestrocel-L
Treasure Global Recieves Canadian MSB Registration for OXI Wallet Expansion
MT Newswires Live  ·  07-02
Treasure Global Recieves Canadian MSB Registration for OXI Wallet Expansion
Is Mesoblast (ASX:MSB) Undervalued Following FDA Progress For Rexlemestrocel L?
Simply Wall St.  ·  07-02
Is Mesoblast (ASX:MSB) Undervalued Following FDA Progress For Rexlemestrocel L?
Mesoblast Receives BLA Filing Number and Requests Modular Review for Rexlemestrocel-L in Patients with End-Stage Heart Failure and LVADs
GlobeNewswire  ·  07-01
Mesoblast Receives BLA Filing Number and Requests Modular Review for Rexlemestrocel-L in Patients with End-Stage Heart Failure and LVADs
OwlTing Group (NASDAQ: OWLS) and Saber Money Open Settlement into India's US$860 Billion Export Economy
GlobeNewswire  ·  06-29
OwlTing Group (NASDAQ: OWLS) and Saber Money Open Settlement into India's US$860 Billion Export Economy
Press Release: Mesoblast Draws US$50 Million from Five-year Non-dilutive Facility
Dow Jones  ·  06-25
Press Release: Mesoblast Draws US$50 Million from Five-year Non-dilutive Facility
Mesoblast (ASX:MSB) Is Up 9.2% After Ryoncil’s Near-US$100m Debut And Revascor FDA Progress – Has The Bull Case Changed?
Simply Wall St.  ·  06-21
Mesoblast (ASX:MSB) Is Up 9.2% After Ryoncil’s Near-US$100m Debut And Revascor FDA Progress – Has The Bull Case Changed?
Mesabi Trust Q1 FY27 net income drops 70.05% to $1.09 million
Reuters  ·  06-13
Mesabi Trust Q1 FY27 net income drops 70.05% to $1.09 million
Press Release: Mesabi Metallics Monetizes Portion of Royalty Interest for $265 Million
Dow Jones  ·  06-02
Press Release: Mesabi Metallics Monetizes Portion of Royalty Interest for $265 Million
The Metals Royalty Company Inc. Closes Mesabi Royalty Acquisition, Exercises Option to Acquire an Additional 1% Royalty Interest and Appoints Michael Hess as Non-Executive Co-Chairman
TIPRANKS  ·  06-02
The Metals Royalty Company Inc. Closes Mesabi Royalty Acquisition, Exercises Option to Acquire an Additional 1% Royalty Interest and Appoints Michael Hess as Non-Executive Co-Chairman
The Metals Royalty Company Acquires Mesabi Royalty; Names Michael Hess as Non-Executive Co-Chairman
MT Newswires Live  ·  06-02
The Metals Royalty Company Acquires Mesabi Royalty; Names Michael Hess as Non-Executive Co-Chairman
Assessing Mesoblast (ASX:MSB) Valuation After Phase 3 Recruitment Milestone For Rexlemestrocel L
Simply Wall St.  ·  05-07
Assessing Mesoblast (ASX:MSB) Valuation After Phase 3 Recruitment Milestone For Rexlemestrocel L
Mesabi Trust Reports Higher Shipments But No Bonus Royalties
TIPRANKS  ·  05-05
Mesabi Trust Reports Higher Shipments But No Bonus Royalties

Introduction

Company Name.
Mesabi
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Mesabi Trust, a royalty trust, engages in iron ore mining business in the United States. Mesabi Trust was founded in 1961 and is based in New York, New York.
Issue price:
--